Diality Inc., a medical device company based in Irvine, Calif., has appointed Ravi Parthasarathy as its new Chief Technology Officer. Parthasarathy brings with him extensive experience in product development team leadership, having most recently worked at ICU Medical as the Vice President of Device Engineering. Prior to that, he held leadership positions at Baxter Healthcare, Motorola, Siemens Medical Systems, and General Motors.
Parthasarathy expressed his excitement about joining Diality, citing the company’s mission of improving the lives of those affected by kidney disease as a significant motivation. “I am thrilled to be joining Diality and contributing to its mission of delivering innovative solutions that improve the quality of life for dialysis patients,” said Parthasarathy.
Diality is committed to delivering innovative solutions that address the needs of both patients and healthcare providers. The Moda-flxTM Hemodialysis System, currently in development, is designed to empower healthcare professionals to make choices that benefit patients and their clinical practice. Osman Khawar, M.D., the CEO of Diality, expressed his excitement about Parthasarathy joining the team, stating that his expertise and alignment with Diality’s mission, vision, and values make him a perfect fit for the company. Additionally, as Diality continues to grow, Clayton Poppe will transition into the role of Chief Scientific Officer (CSO), overseeing the research, quality, and regulatory functions.
For more information about Diality and its products